Table 4.
|
Dorzolamide/timolol treatment |
Brinzolamide/timolol treatment |
Difference between treatment groups |
|||
---|---|---|---|---|---|---|
Variable | Mean (95% CI) difference from timolol baseline | P value | Mean (95% CI) difference from timolol baseline | P value | Mean (95% CI) | P value |
Ophthalmic artery | ||||||
PSV | −0.08 (−1.01 to 0.84) | 0.861 | −0.01 (−0.98 to 0.98) | 0.995 | −1.21 (−2.73 to 0.31) | 0.093 |
EDV | 1.22 (0.90 to 1.56) | <0.001 | 0.02 (−0.26 to 0.30) | 0.865 | 0.96 (0.64 to 1.27) | <0.001 |
RI | −0.04 (−0.05 to −0.03) | <0.001 | 0.00 (−0.01 to 0.01) | 0.713 | −0.04 (−0.05 to −0.03) | <0.001 |
Short posterior ciliary arteries | ||||||
PSV | 1.18 (0.82 to 1.53) | <0.001 | 0.37 (−0.09 to 0.79) | 0.101 | 0.79 (0.36 to 1.21) | <0.001 |
EDV | 0.53 (0.36 to 0.69) | <0.001 | 0.08 (−0.09 to 0.25) | 0.359 | 0.45 (0.26 to 0.65) | <0.001 |
RI | −0.04 (−0.05 to −0.03) | <0.001 | 0.00 (−0.01 to 0.01) | 0.379 | −0.04 (−0.05 to −0.03) | <0.001 |
Central retinal artery | ||||||
PSV | 1.47 (0.94 to 1.99) | <0.001 | 0.38 (−0.14 to 0.89) | 0.155 | 0.83 (0.28 to 1.36) | 0.003 |
EDV | 0.67 (0.43 to 0.91) | <0.001 | 0.10 (−0.13 to 0.34) | 0.409 | 0.47 (0.38 to 0.55) | <0.001 |
RI | −0.04 (−0.05 to −0.03) | <0.001 | 0.00 (−0.01 to 0.01) | 0.643 | −0.04 (−0.05 to −0.03) | 0.002 |
OPP | 4.2 (3.5 to 4.8) | <0.001 | 4.1 (3.4 to 4.8) | <0.001 | 0.1 (−0.8 to 1.4) | 0.555 |
IOP | −4.3 (−4.5 to −4.2) | <0.001 | −4.3 (−4.4 to −4.2) | <0.001 | 0.0 (−0.28 to 0.30) | 0.841 |
Abbreviations: PSV, peak systolic velocity (cm/s); EDV, end diastolic velocity (cm/s); RI, resistance index; OPP, ocular perfusion pressure (mmHg); IOP, intraocular pressure (mmHg).
P values are calculated comparing the parameters at baseline and at the end of the study (two-way ANOVA test); P values were considered statistically significant if lower than 0.005 (Bonferroni correction).